Get the app
Tim Beyers
Motley Fool analyst discussing the Porsche IPO and Biogen's Alzheimer's drug.
Best podcasts with Tim Beyers
Ranked by the Snipd community
Sep 29, 2022
• 28min
An IPO, In This Environment?
chevron_right
Tim Beyers, a seasoned Motley Fool analyst, shares insights on the recent Porsche IPO, highlighting its strategic importance amid the shift to electric vehicles. He delves into why Porsche chose this moment for a public offering while other companies hesitate. Meanwhile, Matt Argersinger discusses rising mortgage rates and their impact on the housing market, addressing the decline in home purchases and emerging trends like home equity loans. They together explore the cautious optimism around Biogen’s experimental Alzheimer's drug and its potential implications.
The AI-powered Podcast Player
Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
Get the app